2Ratz Bravo AE,Tchambaz L,Krahenbuhl-Meicher A,et al.Prevalence of potentially severe drug-drug interactiond in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.Drug Saf,2005,28(3):263
3Koh KK,Quon MJ,Han SH,et al.Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic.hypertensive patients.Circulation,2004,110(24):3687
4Nishio S,Watanabe H,Kosuge K,et al.Interaction between amlodipine and simvastatin in patients with hypercholesterolemia and hypertension.Hypertens Res,2005,28(3)223
5Ziviani L,Da Ros L,Squassante L,et al.The effects of lacididipine on the steady/state plasma concentrations of simvastatin in healthy subjects.Br J Clin Pharmacol,2001,51(2)147
6Georg Nickenig,MD.Should Angiotensin Ⅱ Receptor Blockers and Statins Be Combined? Circulation,2004.110
7Bovd Ra,Stem RH,Stewart BH,et al.Atorvastatin coadministration may increase Digoxin concentrations by inhibition of intestinal P-glycoprotein-mediate secretion.J Clin Pharmacol,2000,40(1):91
8Weber P,Lettieri Jt,Kaiser L,et al.Lack of mutual pharmacokinetic interaction between cervastatin,a new LMG-CoA reductase inhibitor,and digoxin in healthy normocholesterolemic volunteers.Clin Ther,1999,21(9):1563
9Triscari J,Squibb Bn,Willard DA,et al.steady state serum concentrations of pravastatin and digoxin when given in combination.Br J Clin Pharmacol,1993,36(3):263
10Kantola T,Kivisto Kt,Neuvonen PJ.Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations.Clin pharmacol Ther,1999,65(5):583
